DEANA NEAL: Open Payments
NPI 1831868728 · OXFORD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,666 in 98 payments from 22 companies in 2025. Trend: 2023 $351 · 2024 $2,319 · 2025 $1,666
Food & beverage: $1,582Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $449 |
| Janssen Biotech, Inc. | 5 | $163 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $162 |
| Ardelyx, Inc. | 6 | $153 |
| Lilly USA, LLC | 6 | $100 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $98 |
| Aimmune Therapeutics, Inc. | 4 | $71 |
| Regeneron Healthcare Solutions, Inc. | 2 | $58 |
| Phathom Pharmaceuticals, Inc. | 6 | $52 |
| Ipsen Biopharmaceuticals, Inc | 3 | $51 |
Products named: RINVOQ, TREMFYA, ENTYVIO, IBSRELA, OMVOH, DUPIXENT, XIFAXAN, LINZESS.
Industry payments across MS — which companies pay providers there.
